Alcobra Ltd Company Profile (NASDAQ:ADHD)

About Alcobra Ltd (ADHD)

Alcobra Ltd logoAlcobra Ltd is an Israel-based Biopharmaceutical company. It focuses on the development and commercialization of a proprietary drug, MG01CI, to treat Attention Deficit Hyperactivity Disorder (ADHD), a common and morbid neuropsychiatric condition in children and adults. Adult ADHD is associated with increased health risks and healthcare costs, higher divorce rates, lower levels of socioeconomic attainment, lower academic achievement, unemployment and work place deficits, increased risks for motor vehicle accidents, greater likelihood of additional psychiatric disorders, increased criminal activity and incarceration, and higher rates of substance use and abuse. MG01CI product has completed phase two studies.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ADHD
  • CUSIP: N/A
Key Metrics:
  • Previous Close: $1.10
  • 50 Day Moving Average: $1.23
  • 200 Day Moving Average: $2.14
  • 52-Week Range: $0.83 - $5.75
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.96
  • P/E Growth: 0.00
  • Market Cap: $31.42M
  • Outstanding Shares: 27,562,000
  • Beta: 1.33
Profitability:
  • Return on Equity: -38.21%
  • Return on Assets: -36.62%
Debt:
  • Current Ratio: 15.99%
  • Quick Ratio: 15.99%

Analyst Ratings

Consensus Ratings for Alcobra Ltd (NASDAQ:ADHD) (?)
Ratings Breakdown: 1 Sell Rating, 6 Hold Ratings, 3 Buy Ratings
Consensus Rating:Hold (Score: 2.20)
Consensus Price Target: $2.16 (96.75% upside)

Analysts' Ratings History for Alcobra Ltd (NASDAQ:ADHD)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
2/9/2017Roth CapitalUpgradeNeutral -> Buy$4.00N/AView Rating Details
1/18/2017Jefferies Group LLCDowngradeBuy -> Hold$6.00 -> $1.25N/AView Rating Details
1/17/2017Cantor FitzgeraldSet Price TargetHold$2.00N/AView Rating Details
1/17/2017Stifel NicolausSet Price TargetHold$2.00N/AView Rating Details
1/17/2017Oppenheimer Holdings Inc.Reiterated RatingHoldN/AView Rating Details
1/17/2017Piper Jaffray CompaniesSet Price TargetHold$3.00 -> $2.00N/AView Rating Details
11/2/2016WBB SecuritiesUpgradeSell -> Hold$4.00 -> $1.90N/AView Rating Details
10/28/2016Barclays PLCDowngradeEqual Weight -> Underweight$3.00 -> $2.00N/AView Rating Details
9/1/2016Goldman Sachs Group IncReiterated RatingBuyN/AView Rating Details
6/7/2016Canaccord GenuityInitiated CoverageBuyN/AView Rating Details
(Data available from 3/23/2015 forward)

Earnings

Earnings History for Alcobra Ltd (NASDAQ:ADHD)
Earnings by Quarter for Alcobra Ltd (NASDAQ:ADHD)
Earnings History by Quarter for Alcobra Ltd (NASDAQ:ADHD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/17/2017        
11/15/2016Q316($0.26)($0.28)$4.30 million$7.90 millionViewN/AView Earnings Details
8/30/2016Q216($0.22)($0.21)ViewListenView Earnings Details
5/16/2016Q116($0.22)($0.18)ViewListenView Earnings Details
2/17/2016Q415($0.24)($0.20)ViewListenView Earnings Details
11/17/2015Q315($0.31)($0.20)ViewN/AView Earnings Details
8/13/2015Q215($0.30)($0.24)ViewListenView Earnings Details
5/6/2015($0.31)($0.26)ViewN/AView Earnings Details
2/12/2015Q4($0.57)($0.50)ViewN/AView Earnings Details
11/17/2014Q3 14($0.56)($0.77)ViewN/AView Earnings Details
8/11/2014Q2($0.57)($0.57)ViewListenView Earnings Details
5/15/2014Q114($0.57)ViewN/AView Earnings Details
2/13/2014Q413($0.35)($0.45)ViewN/AView Earnings Details
11/7/2013Q313($0.28)ViewN/AView Earnings Details
8/6/2013Q213($0.06)($0.15)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Alcobra Ltd (NASDAQ:ADHD)
Current Year EPS Consensus Estimate: $-0.68 EPS
Next Year EPS Consensus Estimate: $-0.56 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163($0.19)($0.15)($0.17)
Q2 20163($0.22)($0.20)($0.21)
Q3 20163($0.29)($0.25)($0.27)
Q4 20163($0.36)($0.16)($0.27)
Q1 20172($0.25)($0.15)($0.20)
Q2 20172($0.23)($0.13)($0.18)
Q3 20172($0.18)($0.14)($0.16)
Q4 20172($0.19)($0.15)($0.17)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Alcobra Ltd (NASDAQ:ADHD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Alcobra Ltd (NASDAQ:ADHD)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Alcobra Ltd (NASDAQ:ADHD)
Latest Headlines for Alcobra Ltd (NASDAQ:ADHD)
Source:
DateHeadline
streetinsider.com logoBrosh Capital Requests Extraordinary General Meeting at Alcobra (ADHD), Seeks to Remove Board in Full - StreetInsider.com (NASDAQ:ADHD)
www.streetinsider.com - March 18 at 3:18 PM
finance.yahoo.com logoIMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Alcobra, Ltd., and Encourages Investors with Losses to Contact the Firm (NASDAQ:ADHD)
finance.yahoo.com - March 18 at 1:42 AM
finance.yahoo.com logoBrosh Capital Delivers Extraordinary General Meeting Request To Alcobra And Issues Letter To Chairman (NASDAQ:ADHD)
finance.yahoo.com - March 16 at 4:52 PM
finance.yahoo.com logo12:36 pm Alcobra stockholder Brosh Capital delivers letter to the co's Board requesting an 'Extraordinary General Meeting of Shareholders in order to remove the existing Board in full, and nominate its six highly-qualified directors' (NASDAQ:ADHD)
finance.yahoo.com - March 16 at 4:52 PM
News IconAlcobra Ltd (ADHD) Downgraded to “Hold” at Zacks Investment Research (NASDAQ:ADHD)
www.americanbankingnews.com - March 15 at 9:33 PM
finance.yahoo.com logoIMPORTANT INVESTOR NOTICE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Alcobra, Ltd., and Encourages Investors with Losses to Contact the Firm (NASDAQ:ADHD)
finance.yahoo.com - March 15 at 3:26 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Alcobra, Ltd. (ADHD) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit (NASDAQ:ADHD)
finance.yahoo.com - March 14 at 8:18 PM
News IconAlcobra Ltd (ADHD) Upgraded to “Buy” at Zacks Investment Research (NASDAQ:ADHD)
www.americanbankingnews.com - March 14 at 8:31 AM
finance.yahoo.com logoIMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Alcobra, Ltd., and Encourages Investors with Losses to Contact the Firm (NASDAQ:ADHD)
finance.yahoo.com - March 9 at 3:22 PM
News IconZacks Investment Research Downgrades Alcobra Ltd (ADHD) to Hold (NASDAQ:ADHD)
www.americanbankingnews.com - March 7 at 10:39 PM
News IconStock Analysts’ Updated EPS Estimates for March, 7th (ADHD, ADRO, AFLYY, AMRC, AMRS, APTS, ASBFY, CELP, CHOLY, CHSP) (NASDAQ:ADHD)
www.americanbankingnews.com - March 7 at 10:39 PM
finance.yahoo.com logoAlcobra Ltd. to Participate in Upcoming Healthcare Conferences (NASDAQ:ADHD)
finance.yahoo.com - March 7 at 3:21 PM
finance.yahoo.com logoINVESTOR ALERT: Lundin Law PC Announces an Investigation of Alcobra, Ltd. and Encourages Investors with Losses to Contact the Firm (NASDAQ:ADHD)
finance.yahoo.com - March 3 at 3:31 PM
globenewswire.com logoAlcobra to Host Investor Forum and Webcast on March 28 in New ... - GlobeNewswire (press release) (NASDAQ:ADHD)
globenewswire.com - March 1 at 3:20 PM
finance.yahoo.com logoINVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Alcobra, Ltd. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit (NASDAQ:ADHD)
finance.yahoo.com - March 1 at 3:20 PM
finance.yahoo.com logoAlcobra to Host Investor Forum and Webcast on March 28 in New York City (NASDAQ:ADHD)
finance.yahoo.com - March 1 at 8:31 AM
globenewswire.com logoIMPORTANT ALCOBRA LTD. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a ... - GlobeNewswire (press release) (NASDAQ:ADHD)
globenewswire.com - February 25 at 3:17 PM
us.rd.yahoo.com logoIMPORTANT ALCOBRA LTD. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the Southern District of New York on behalf of purchasers of Alcobra Ltd. (NASDAQ:ADHD)
us.rd.yahoo.com - February 24 at 8:20 PM
finance.yahoo.com logoGlancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Alcobra Ltd. Investors and Encourages Investors to Contact the Firm (NASDAQ:ADHD)
finance.yahoo.com - February 24 at 3:19 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of Alcobra, Ltd. and Encourages Investors with Losses to Contact the Firm (NASDAQ:ADHD)
finance.yahoo.com - February 24 at 3:19 PM
globenewswire.com logoSHAREHOLDER ALERT: Brower Piven Notifies Investors of Class ... - GlobeNewswire (press release) (NASDAQ:ADHD)
globenewswire.com - February 24 at 9:47 AM
finance.yahoo.com logoThe Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Alcobra Ltd. Investors and Encourages Investors to Contact the Firm (NASDAQ:ADHD)
finance.yahoo.com - February 23 at 8:21 PM
finance.yahoo.com logoIMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Alcobra, Ltd., and Encourages Investors with Losses to Contact the Firm (NASDAQ:ADHD)
finance.yahoo.com - February 23 at 8:21 PM
finance.yahoo.com logoINVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit against Alcobra, Ltd. and Encourages Investors with Losses to Contact the Firm (NASDAQ:ADHD)
finance.yahoo.com - February 23 at 3:20 PM
prnewswire.com logoLifshitz & Miller LLP Files Class Action Lawsuit against Alcobra, Ltd. - PR Newswire (press release) (NASDAQ:ADHD)
www.prnewswire.com - February 17 at 6:47 PM
finance.yahoo.com logoLifshitz & Miller LLP Files Class Action Lawsuit against Alcobra, Ltd. (NASDAQ:ADHD)
finance.yahoo.com - February 17 at 6:47 PM
finance.yahoo.com logoIMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Alcobra, Ltd., and Encourages Investors with Losses to Contact the Firm (NASDAQ:ADHD)
finance.yahoo.com - February 17 at 6:47 PM
seekingalpha.com logoAlcobra (ADHD) Presents At 19th Annual BIO CEO & Investor Conference - Slideshow (NASDAQ:ADHD)
seekingalpha.com - February 16 at 3:20 PM
us.rd.yahoo.com logoAlcobra Announces Fourth-Quarter and Full-Year 2016 Financial Results and Provides Corporate Update (NASDAQ:ADHD)
us.rd.yahoo.com - February 16 at 3:20 PM
biz.yahoo.com logoQ4 2016 Alcobra Ltd Earnings Release - 08:30 am ET (NASDAQ:ADHD)
us.rd.yahoo.com - February 16 at 3:20 PM
us.rd.yahoo.com logo7:08 am Alcobra provides Q4 results (NASDAQ:ADHD)
us.rd.yahoo.com - February 16 at 3:20 PM
globenewswire.com logoAlcobra Announces Fourth-Quarter and Full-Year 2016 Financial ... - GlobeNewswire (press release) (NASDAQ:ADHD)
globenewswire.com - February 16 at 6:32 AM
finance.yahoo.com logoEdited Transcript of ADHD earnings conference call or presentation 15-Feb-17 1:30pm GMT (NASDAQ:ADHD)
finance.yahoo.com - February 16 at 6:32 AM
feeds.benzinga.com logoAlcobra Ltd. to Release Fiscal 2016 Financial Results and Participate at the BIO CEO & Investor Conference in New York (NASDAQ:ADHD)
feeds.benzinga.com - February 8 at 8:54 AM
nasdaq.com logoHealth Care Sector Update for 02/07/2017: ADHD,ARWR,ATNM - Nasdaq (NASDAQ:ADHD)
www.nasdaq.com - February 7 at 8:25 PM
streetinsider.com logoAlcobra Ltd. (ADHD) Reports on Productive FDA Meeting on ADAIR - StreetInsider.com (NASDAQ:ADHD)
www.streetinsider.com - February 7 at 3:25 PM

Social

Frequently Asked Questions for Alcobra Ltd (NASDAQ:ADHD)

What is Alcobra Ltd's stock symbol?

Alcobra Ltd trades on the NASDAQ under the ticker symbol "ADHD."

How were Alcobra Ltd's earnings last quarter?

Alcobra Ltd (NASDAQ:ADHD) released its quarterly earnings results on Tuesday, August, 30th. The company reported ($0.21) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.22) by $0.01.

When will Alcobra Ltd make its next earnings announcement?

Alcobra Ltd is scheduled to release their next quarterly earnings announcement on Wednesday, May, 17th 2017.

Where is Alcobra Ltd's stock going? Where will Alcobra Ltd's stock price be in 2017?

10 analysts have issued 12-month price targets for Alcobra Ltd's stock. Their forecasts range from $1.25 to $4.00. On average, they expect Alcobra Ltd's stock price to reach $2.16 in the next twelve months.

What are analysts saying about Alcobra Ltd stock?

Here are some recent quotes from research analysts about Alcobra Ltd stock:

  • 1. According to Zacks Investment Research, "Alcobra Ltd. is a biopharmaceutical company. It focuses on the development and commercialization of drugs to treat attention deficit hyperactivity disorder. Alcobra Ltd. is headquartered in Tel Aviv, Israel. " (3/15/2017)
  • 2. Piper Jaffray Companies analysts commented, "We're not particularly surprised by this outcome as the truncated dataset greatly reduced the power of this trial to demonstrate a significant impact on the CAARS. Alcobra now plans to use its ~$50M in cash to execute on a new business plan, the details of which should become available during 1Q17. We expect this could involve development of MDX in ex-US markets, or of new candidates from the company's internal pipeline or in-licensing efforts. Given the prolonged timelines to next clinical data and first revenues, as well as increased execution risk we see for this team, we are reducing our PT from $3 to $1.50, or roughly equivalent to cash/share. In advance of more details on a plan forward, we reiterate N." (1/17/2017)

Are investors shorting Alcobra Ltd?

Alcobra Ltd saw a increase in short interest in the month of February. As of February 15th, there was short interest totalling 1,115,643 shares, an increase of 47.8% from the January 31st total of 754,914 shares. Based on an average trading volume of 1,490,584 shares, the days-to-cover ratio is presently 0.7 days. Currently, 5.5% of the shares of the company are sold short.

Who owns Alcobra Ltd stock?

Alcobra Ltd's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Franklin Resources Inc. (16.25%), BROSH CAPITAL L.P. (9.40%), BROSH CAPITAL L.P. (9.00%), Broadfin Capital LLC (7.46%), Alyeska Investment Group L.P. (2.96%) and Kingdon Capital Management L.L.C. (2.36%).

Who sold Alcobra Ltd stock? Who is selling Alcobra Ltd stock?

Alcobra Ltd's stock was sold by a variety of institutional investors in the last quarter, including Alyeska Investment Group L.P..

Who bought Alcobra Ltd stock? Who is buying Alcobra Ltd stock?

Alcobra Ltd's stock was purchased by a variety of institutional investors in the last quarter, including Franklin Resources Inc., Royce & Associates LP, J. Goldman & Co LP, Kingdon Capital Management L.L.C. and Broadfin Capital LLC.

How do I buy Alcobra Ltd stock?

Shares of Alcobra Ltd can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Alcobra Ltd stock cost?

One share of Alcobra Ltd stock can currently be purchased for approximately $1.10.

Alcobra Ltd (ADHD) Chart for Thursday, March, 23, 2017

This page was last updated on 3/23/2017 by MarketBeat.com Staff